Bristol-Myers Squibb
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $12,342,000 | $11,892,000 | $12,201,000 | $11,865,000 |
Gross Profit | 7,530,000 | 8,935,000 | 6,801,000 | 8,933,000 |
EBITDA | 2,551,000 | 4,773,000 | 4,368,000 | -8,536,000 |
EBIT | 671,000 | 2,181,000 | 1,807,000 | -11,091,000 |
Net Income | 72,000 | 1,211,000 | 1,680,000 | -11,911,000 |
Net Change In Cash | 12,342,000 | 11,892,000 | 12,201,000 | 11,865,000 |
Free Cash Flow | 4,061,000 | 5,267,000 | 2,064,000 | 2,550,000 |
Cash | 10,346,000 | 7,890,000 | 6,295,000 | 9,330,000 |
Basic Shares | 2,037,000 | 2,031,000 | 2,029,000 | 2,023,000 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $48,300,000 | $45,006,000 | $46,159,000 | $46,385,000 |
Gross Profit | 36,351,000 | 34,313,000 | 36,022,000 | 36,445,000 |
EBITDA | 3,168,000 | 19,417,000 | 19,232,000 | 20,191,000 |
EBIT | -6,432,000 | 9,606,000 | 8,945,000 | 9,432,000 |
Net Income | -8,948,000 | 8,025,000 | 6,327,000 | 6,994,000 |
Net Change In Cash | 48,300,000 | 45,006,000 | 46,159,000 | 46,385,000 |
Cost of Revenue | -4,958,000 | -555,000 | ||
Free Cash Flow | 13,942,000 | 12,651,000 | 11,948,000 | 15,234,000 |
Cash | 10,346,000 | 11,464,000 | 9,123,000 | 13,979,000 |
Basic Shares | 2,027,000 | 2,078,000 | 2,146,000 | 2,245,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $1.67 |
2024-09-30 | $1.80 |
2024-06-30 | $2.07 |
2024-03-31 | -$4.40 |
